SectorPharmaceutical
Established Date--
Listing Date26/03/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees146
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1715 38th St., Boulder, CO 80301
Business
IntroductionEdgewise Therapeutics, Inc., was incorporated in Delaware in May 2017. The company is a science-driven biotechnology company focused on developing therapies for serious muscle diseases, with the initial target of rare neuromuscular and heart diseases. Its lead drug candidate sevasemten is an oral small molecule inhibitor that is in late-stage clinical development for the treatment of Duchenne muscular dystrophy and Becker muscular dystrophy.
